Cancer Medicines to Cost Less From 9 November 2026: NPPA Caps Trade Margins on 137 Drugs — How to Check the New MRP and Complain If You Are Overcharged
Cancer treatment can place a heavy financial burden on patients and families. The Government of India has announced a new price-control measure covering 137 non-scheduled anti-cancer medicines, with revised maximum retail prices (MRPs) taking effect on 9 November 2026.
The National Pharmaceutical Pricing Authority (NPPA) issued the notification on 17 October 2026 under the Drugs (Prices Control) Order, 2013. The measure caps trade margins at 30% under the prescribed pricing formula and is expected to reduce the MRPs of affected medicines by up to 70%, depending on their existing prices. <Cite refs={["turn462430search0","turn462430search1"]}/>
Key Details at a Glance
| Detail | Information |
|---|---|
| Authority | National Pharmaceutical Pricing Authority (NPPA) |
| Medicines covered | 137 identified non-scheduled anti-cancer drugs |
| Trade margin cap | 30% under the prescribed formula |
| Notification date | 17 October 2026 |
| Revised prices effective from | 9 November 2026 |
| Expected price reduction | Up to 70%; actual reductions vary |
| Official website | nppa.gov.in |
<Cite refs={["turn462430search0","turn462430search1"]}/>
Which Cancer Medicines Are Covered?
The notified list includes medicines used in cancer treatment and the management of treatment-related complications. Examples include:
| Medicine | General use |
|---|---|
| Pembrolizumab | Immunotherapy for certain cancers |
| Durvalumab | Immunotherapy for certain cancers |
| Osimertinib | Targeted treatment for certain lung cancers |
| Ribociclib | Targeted treatment for certain breast cancers |
| Bevacizumab | Treatment for certain cancers |
| Denosumab | Used in specified cancer-related settings |
| Pegfilgrastim | Helps prevent certain chemotherapy-related complications |
These are examples, not the complete list of 137 medicines. Inclusion and pricing depend on the exact formulation and applicable notification. Check the official NPPA order before assuming a particular brand or pack is covered. <Cite refs={["turn462430search0","turn462430search3"]}/>
How to Check the New MRP
From 9 November 2026, patients and caregivers can use these steps to verify prices.
- Identify the exact medicine. Note its name, strength, dosage form, brand and pack size.
- Check the updated price list. Visit the NPPA website and look for the notification and revised price information.
- Use Pharma Sahi Daam. The government identifies the Pharma Sahi Daam app as another way to check medicine prices.
- Compare the applicable MRP. Match the medicine and pack carefully. Different strengths and formulations may have different prices.
- Keep the bill. Save the invoice and, where relevant, a photograph of the medicine pack showing its printed MRP.
The revised prices take effect on 9 November, so do not assume that a new price applies before that date. <Cite refs={["turn462430search0","turn462430search9"]}/>
What If a Pharmacy or Hospital Charges Too Much?
If you believe you have been charged above the applicable revised price, first compare the invoice with the correct notified price for the exact formulation and pack.
| Step | What to do |
|---|---|
| 1. Collect evidence | Keep the bill, medicine-pack photograph, date of purchase and pack details. |
| 2. Ask for clarification | Request the pharmacy or hospital to explain the difference and provide the applicable price list. |
| 3. Contact NPPA | Use the official NPPA website to locate its public-grievance or overcharging complaint service. |
| 4. Contact the State Drug Controller | Report suspected non-compliance to the drug-control authority in your state. |
| 5. Retain the reference number | Keep the complaint acknowledgement and any supporting correspondence. |
For medicines supplied directly by hospitals, the government has specifically placed responsibility on hospitals and medical institutions to ensure the revised prices are followed from the implementation date. State Drug Controllers are responsible for monitoring compliance. <Cite refs={["turn462430search0","turn462430search1"]}/>
Important Things Patients Should Know
- A reduction of 70% is not guaranteed for every medicine. The actual change depends on the existing price and the notified pricing calculation.
- Check the exact formulation. A different strength, dosage form or pack may have a different applicable price.
- Do not stop or change cancer treatment based on price news alone. Discuss alternatives or treatment changes with your oncologist.
- Ask for an itemised bill. This helps distinguish the medicine price from other hospital or treatment charges.
- Do not rely on old price screenshots. Check the latest applicable price list and the date on which the revised MRP takes effect.
Official Links
- National Pharmaceutical Pricing Authority (NPPA)
- Department of Pharmaceuticals
- Government announcement dated 17 October 2026
Final Takeaway
From 9 November 2026, revised prices will apply to 137 identified non-scheduled anti-cancer medicines under the NPPA’s new trade-margin rules. Patients should check the exact medicine and pack against the official price list, retain purchase bills and report suspected overcharging to NPPA or their State Drug Controller.
A quick price check before purchase can help patients and caregivers avoid paying more than the applicable notified price.